Poster Session 3
Sami Backley, MD
Clinical Fellow PGY 9
Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Eric P. Bergh, MD
Associate Professor
Nemours Children's Health
Wilmington, Delaware, United States
Felicia V. LeMoine, MD (she/her/hers)
Fetal Intervention Fellow
Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Neha Agarwal, MBBS, MD
Post doctoral Research Fellow
Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, UTHealth McGovern Medical School, Houston, TX, USA
Houston, Texas, United States
Gustavo Vilchez, MD, MSCR
UTHealth Houston
Houston, Texas, United States
Ashley Salazar, DNP
Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at UT Health Houston
Houston, Texas, United States
Edgar A. Hernandez-Andrade, MD, PhD (he/him/his)
Professor
McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Anthony Johnson, DO
Professor
McGovern Medical School University of Texas Health Science Center at Houston (UThealth)
Houston, Texas, United States
Ramesha Papanna, MD, MPH
Professor
McGovern Medical School at UTHealth Houston
Houston, Texas, United States
Jimmy Espinoza, MD, MSc
Professor
Division of Fetal Intervention, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at UTHealth Houston
Houston, Texas, United States
PPROM remains a major complication of FLS resulting in an earlier GA at delivery. CAS is the most important risk factor for PPROM after FLS surgery while amnioinfusion of ≥1 L is not a risk factor for PPROM following FLS for the management of TTTS.